荣泰健康(603579) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥616,647,798.61, representing a year-on-year increase of 17.14%[5] - The net profit attributable to shareholders for the same period was ¥48,230,369.16, showing a decrease of 20.36% compared to the previous year[5] - The basic earnings per share for Q3 2021 was ¥0.36, down 18.18% year-on-year[6] - Total operating revenue for the first three quarters of 2021 reached ¥1,865,025,360.07, a significant increase from ¥1,405,243,697.89 in the same period of 2020, representing a growth of approximately 32.7%[19] - Net profit for the first three quarters of 2021 was ¥184,784,809.14, up from ¥150,533,424.81 in 2020, reflecting a growth of approximately 22.7%[20] - Earnings per share for the first three quarters of 2021 were ¥1.39, compared to ¥1.17 in the same period of 2020, marking an increase of 18.8%[21] - The total comprehensive income for the first three quarters of 2021 was ¥183,547,529.53, compared to ¥149,805,591.53 in 2020, reflecting an increase of approximately 22.6%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥3,071,148,483.00, reflecting a 4.10% increase from the end of the previous year[6] - The company’s equity attributable to shareholders increased by 3.38% to ¥1,715,500,457.44 compared to the previous year[6] - The total liabilities as of the end of the third quarter of 2021 amounted to ¥1,368,382,278.67, an increase from ¥1,299,988,643.69 at the end of 2020[20] - The company’s total assets as of the end of the third quarter of 2021 were ¥3,071,148,483.00, compared to ¥2,950,273,548.05 at the end of 2020[20] - Total liabilities included accounts payable of CNY 530,522,198.80 and contract liabilities of CNY 70,185,970.92[28] Cash Flow - The cash flow from operating activities for the year-to-date was ¥48,637,088.37, a decrease of 25.48%[6] - The company reported a total cash inflow from operating activities of ¥1,858,742,048.48 for the first three quarters of 2021, compared to ¥1,368,554,285.47 in the same period of 2020[23] - Operating cash inflow for Q3 2021 was CNY 2,001,270,555.83, an increase from CNY 1,507,770,747.49 in Q3 2020, representing a growth of approximately 32.7%[24] - The company reported a net cash flow from operating activities of CNY 48,637,088.37, down from CNY 65,264,870.16 in Q3 2020[24] Costs and Expenses - The company's operating costs increased by 43.05%, primarily due to rising raw material prices and adjustments in expense classifications[9] - Total operating costs for the first three quarters of 2021 were ¥1,678,950,250.44, compared to ¥1,242,435,966.80 in the previous year, indicating an increase of about 35.1%[20] - Research and development expenses for the first three quarters of 2021 were ¥88,671,626.60, up from ¥72,309,443.79 in 2020, indicating a growth of about 22.7%[20] Investments and Subsidies - The company reported a significant increase in investment income of 154.30% year-on-year, attributed to higher returns from financial investments[9] - The company received government subsidies amounting to ¥7,199,149.85 during the reporting period, which is an increase compared to the previous year[8] Stock and Equity - The company approved a restricted stock incentive plan during the board meetings held on August 26 and September 14, 2021, aimed at enhancing employee motivation and retention[14] - The total equity attributable to shareholders reached ¥1,715,500,457.44, compared to ¥1,659,416,997.40 in the previous year, showing an increase of approximately 3.4%[20] Current Assets and Inventory - The company's current assets totaled RMB 1,923,648,574.52, compared to RMB 1,816,811,642.31 at the end of 2020, indicating an increase of about 5.9%[16] - Accounts receivable increased by 83.25%, mainly due to the rise in operating revenue[9] - Inventory increased significantly to RMB 318,526,186.79, compared to no previous figure provided, indicating a strong focus on stock management[16] Cash and Equivalents - Cash and cash equivalents decreased to RMB 672,056,093.95 from RMB 882,664,744.58, reflecting a decline of approximately 23.8%[16] - Cash received from other operating activities was CNY 45,203,895.74, a decrease from CNY 63,226,543.93 in the previous year[24] Other Financial Metrics - The company incurred cash payments for employee compensation totaling CNY 179,157,879.18, compared to CNY 155,466,176.01 in Q3 2020[24] - The company experienced a negative impact of CNY -4,268,906.29 from foreign exchange fluctuations on cash and cash equivalents[25] Accounting Changes - The company adopted new leasing standards effective January 1, 2021, adjusting retained earnings and related financial statement items accordingly[30]